Ring-substituted imidazoles as a new class of anti-tuberculosis agents
P Gupta, S Hameed, R Jain
Index: Gupta, Preeti; Hameed, Shahul; Jain, Rahul European Journal of Medicinal Chemistry, 2004 , vol. 39, # 9 p. 805 - 814
Full Text: HTML
Citation Number: 83
Abstract
We describe in vitro anti-Mycobacterium tuberculosis activities of ring-substituted-1H- imidazole-4-carboxylic acid derivatives (1–6), and 3-(2-alkyl-1H-imidazol-4-yl)-propionic acid derivatives (7–13) against drug-sensitive and drug-resistant M. tuberculosis H37Rv strains. The most effective analogues, 2f (R= R1= c-C5H9), and 2h (R= R1= c-C6H11) have produced> 90% inhibition at a concentration of< 6.25 μg/ml in the drug-sensitive screen. ...
Related Articles:
[Agelis, George; Resvani, Amalia; Matsoukas, Minos-Timotheos; Tselios, Theodore; Kelaidonis, Konstantinos; Kalavrizioti, Dimitra; Vlahakos, Demetrios; Matsoukas, John Amino Acids, 2011 , vol. 40, # 2 p. 411 - 420]
Facile Syntheses of Histamine-and Imidazole-4-propionic Acid–Derived Room-Temperature Ionic Liquids
[Dubey, Ravi Kant; Kumar, Neeraj; Jain, Rahul Synthetic Communications, 2012 , vol. 42, # 15 p. 2207 - 2216]
Ring-substituted imidazoles as a new class of anti-tuberculosis agents
[European Journal of Medicinal Chemistry, , vol. 39, # 9 p. 805 - 814]
Highly selective inhibitors of thromboxane synthetase. 1. Imidazole derivatives
[Journal of Medicinal Chemistry, , vol. 24, # 10 p. 1139 - 1148]
Highly selective inhibitors of thromboxane synthetase. 1. Imidazole derivatives
[Journal of Medicinal Chemistry, , vol. 24, # 10 p. 1139 - 1148]